Variant report

Variant	esv994926
Chromosome Location	chr19:56863012-56870930
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:56866390-56867520	HepG2	liver:	n/a	n/a
2	BACH1	chr19:56868468-56868645	K562	blood:	n/a	n/a
3	CBX3	chr19:56868281-56868662	K562	blood:	n/a	n/a
4	CBX3	chr19:56868338-56868616	K562	blood:	n/a	n/a
5	CEBPB	chr19:56867598-56867926	HepG2	liver:	n/a	chr19:56867757-56867768
6	CEBPB	chr19:56864074-56864274	HepG2	liver:	n/a	n/a
7	CEBPB	chr19:56868669-56868820	HepG2	liver:	n/a	n/a
8	CEBPB	chr19:56866960-56867199	HepG2	liver:	n/a	n/a
9	CTCF	chr19:56869292-56869357	LNCaP	prostate:	n/a	n/a
10	CTCF	chr19:56870343-56870393	LNCaP	prostate:	n/a	n/a
11	EP300	chr19:56866943-56867306	HepG2	liver:	n/a	n/a
12	EP300	chr19:56866783-56867261	HepG2	liver:	n/a	n/a
13	FOXA1	chr19:56866757-56867170	HepG2	liver:	n/a	chr19:56867126-56867138
14	FOXA1	chr19:56866754-56867348	HepG2	liver:	n/a	chr19:56867126-56867138
15	FOXA1	chr19:56866798-56867266	HepG2	liver:	n/a	chr19:56867126-56867138
16	FOXA1	chr19:56866747-56867374	HepG2	liver:	n/a	chr19:56867126-56867138
17	FOXA2	chr19:56866848-56867211	HepG2	liver:	n/a	chr19:56867126-56867138
18	FOXA2	chr19:56866419-56867578	HepG2	liver:	n/a	chr19:56867126-56867138
19	HNF4A	chr19:56866844-56867258	HepG2	liver:	n/a	chr19:56867018-56867031 chr19:56867017-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867018-56867030 chr19:56867015-56867033 chr19:56867018-56867031
20	HNF4A	chr19:56866857-56867210	HepG2	liver:	n/a	chr19:56867018-56867031 chr19:56867017-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867018-56867030 chr19:56867015-56867033 chr19:56867018-56867031
21	HNF4G	chr19:56866916-56867138	HepG2	liver:	n/a	chr19:56867018-56867031 chr19:56867017-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867017-56867031 chr19:56867018-56867030 chr19:56867018-56867030 chr19:56867017-56867032 chr19:56867015-56867033 chr19:56867018-56867031
22	JUND	chr19:56868461-56868610	K562	blood:	n/a	chr19:56868533-56868544
23	JUND	chr19:56868515-56868638	HepG2	liver:	n/a	chr19:56868533-56868544
24	KAP1	chr19:56867955-56868625	K562	blood:	n/a	n/a
25	MAFF	chr19:56868354-56868666	K562	blood:	n/a	n/a
26	MAFK	chr19:56868446-56868656	K562	blood:	n/a	n/a
27	NFIC	chr19:56866807-56867338	HepG2	liver:	n/a	n/a
28	POLR2A	chr19:56866837-56866897	MCF10A-Er-Src	breast:	n/a	n/a
29	POLR2A	chr19:56863115-56863186	ProgFib	skin:	n/a	n/a
30	POLR2A	chr19:56863465-56863622	ProgFib	skin:	n/a	n/a
31	RCOR1	chr19:56868480-56868514	K562	blood:	n/a	n/a
32	RXRA	chr19:56866913-56867231	HepG2	liver:	n/a	chr19:56867017-56867026
33	SP1	chr19:56866842-56867321	HepG2	liver:	n/a	n/a
34	STAT3	chr19:56867222-56867414	MCF10A-Er-Src	breast:	n/a	n/a
35	TCF7L2	chr19:56866788-56867248	HepG2	liver:	n/a	n/a
36	TRIM28	chr19:56868272-56868676	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:56861231..56863974-chr19:56864374..56866865,3	K562	blood:
2	chr19:56861231..56864651-chr19:56864910..56868187,3	K562	blood:
3	chr19:56861231..56864651-chr19:56864910..56868187,3	K562	blood:
4	chr19:56861231..56863974-chr19:56864374..56866865,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZSCAN5A-3	chr19:56865862-56866010	ENSG00000267606.1

Variant related genes	Relation type
ENSG00000267429	TF binding region

Extended variants
information (count: 334 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:334 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531651787	chr19:56863027-56863028	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs548576094	chr19:56863066-56863067	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs560980972	chr19:56863077-56863078	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs371933795	chr19:56863107-56863108	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs8109340	chr19:56863145-56863146	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs370231943	chr19:56863167-56863168	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs546351661	chr19:56863187-56863188	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs77819594	chr19:56863192-56863193	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs11672336	chr19:56863207-56863208	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs369252788	chr19:56863209-56863210	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs139573357	chr19:56863222-56863223	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs556126006	chr19:56863249-56863250	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs537402155	chr19:56863285-56863286	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs554552368	chr19:56863291-56863292	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs2058319	chr19:56863306-56863307	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs534532305	chr19:56863307-56863308	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs8109555	chr19:56863358-56863359	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs577561224	chr19:56863372-56863373	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs149679849	chr19:56863380-56863381	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147803054	chr19:56863382-56863383	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs115522346	chr19:56863397-56863398	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs541832305	chr19:56863414-56863415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs112518359	chr19:56863424-56863425	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs375926692	chr19:56863459-56863460	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs540162277	chr19:56863467-56863468	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs201559754	chr19:56863571-56863572	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs368638199	chr19:56863572-56863573	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs114062640	chr19:56863615-56863616	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs532212794	chr19:56863619-56863620	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs541246343	chr19:56863658-56863659	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs11672540	chr19:56863668-56863669	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs182543493	chr19:56863682-56863683	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs531457209	chr19:56863712-56863713	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs375856804	chr19:56863753-56863754	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs533658341	chr19:56863814-56863815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs115238818	chr19:56863917-56863918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs147569698	chr19:56863956-56863957	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs534494527	chr19:56863967-56863968	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs554546962	chr19:56864002-56864003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs571172286	chr19:56864004-56864005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs377690021	chr19:56864041-56864042	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs539993757	chr19:56864092-56864093	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs149217158	chr19:56864136-56864137	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs187587515	chr19:56864175-56864176	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs542341028	chr19:56864179-56864180	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs143399085	chr19:56864204-56864205	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs2109468	chr19:56864216-56864217	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs2109469	chr19:56864229-56864230	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs559976379	chr19:56864244-56864245	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs534027434	chr19:56864245-56864246	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Alzheimer''s disease	22166940	CNVD
Heart disease	21282601	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Glioblastoma multiforme	21922591	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Glioma	20126413	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:29 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:56854200-56863200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
2	chr19:56855000-56870200	Weak transcription	Duodenum Smooth Muscle	Duodenum
3	chr19:56859400-56872800	Weak transcription	Ovary	ovary
4	chr19:56862000-56868400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr19:56862400-56863400	Enhancers	iPS-18 Cell Line	embryonic stem cell
6	chr19:56862400-56866400	Weak transcription	Right Atrium	heart
7	chr19:56862800-56863400	Enhancers	iPS-15b Cell Line	embryonic stem cell
8	chr19:56863000-56872800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr19:56863800-56864000	Enhancers	Brain Substantia Nigra	brain
10	chr19:56863800-56864600	Enhancers	HepG2	liver
11	chr19:56864000-56864400	Enhancers	Brain Hippocampus Middle	brain
12	chr19:56864000-56864400	Weak transcription	Brain Substantia Nigra	brain
13	chr19:56864400-56864600	ZNF genes & repeats	Brain Substantia Nigra	brain
14	chr19:56864400-56864800	ZNF genes & repeats	Liver	Liver
15	chr19:56864600-56865600	Weak transcription	Brain Substantia Nigra	brain
16	chr19:56864600-56865800	Weak transcription	HepG2	liver
17	chr19:56864800-56865400	Weak transcription	Liver	Liver
18	chr19:56865400-56865800	Active TSS	Liver	Liver
19	chr19:56865800-56867200	Enhancers	Liver	Liver
20	chr19:56865800-56867200	Enhancers	HepG2	liver
21	chr19:56866200-56871000	Weak transcription	Primary T cells from cord blood	blood
22	chr19:56866800-56867600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
23	chr19:56867200-56867600	Flanking Active TSS	HepG2	liver
24	chr19:56867200-56867800	Flanking Active TSS	Liver	Liver
25	chr19:56867600-56867800	ZNF genes & repeats	Brain Dorsolateral Prefrontal Cortex	brain
26	chr19:56867600-56868400	Enhancers	HepG2	liver
27	chr19:56867800-56868000	Enhancers	Liver	Liver
28	chr19:56868400-56868800	ZNF genes & repeats	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr19:56869400-56872400	Weak transcription	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links